Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3718-3729
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3718
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3718
Figure 3 Response of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio according to chemotherapy.
NLR: Neutrophil/lymphocyte ratio; PLR: Platelet/lymphocyte ratio; GA: Gemcitabine plus nab-paclitaxel; FFX: FOLFIRINOX.
- Citation: Han SY, Kim DU, Seol YM, Kim S, Lee NK, Hong SB, Seo HI. Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. World J Clin Cases 2020; 8(17): 3718-3729
- URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3718.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3718